Project Report for Surgical Cotton
Understanding product complexity, target clients, regulatory needs, and investment requirements are all necessary for an operational table business. The table’s design and features have a direct influence on production costs and market potential. Sharda Associates, a Bhopal-based CA and financial consultancy firm, provides CA-certified project reports for entrepreneurs and MSMEs entering regulated manufacturing enterprises, starting at ₹2,999 depending on project requirements.
Get free Sample
Why "Blood Test Kit" Isn't One Category
In India, these items are regulated as In Vitro Diagnostic (IVD) medical devices under the Medical Device Rules, 2017. CDSCO categorizes each IVD into one of four risk groups — A, B, C, or D — based on how the result is utilized and what occurs if it is incorrect. A simple screening test with an error requiring a follow-up lab test is at the lower end. A test whose incorrect result could result in a hazardous blood transfusion or a missed infectious illness diagnosis is at the top.
Many new entrants are surprised to learn that HIV testing kits and blood-screening IVDs are classified as Class D, the highest risk category in the entire system, with additional requirements such as performance evaluation against Indian epidemiology (the kit must reliably detect the specific viral strains found in Indian patients) and, in some cases, review by the National AIDS Control Organization (NACO) in addition to standard CDSCO clearance. A basic glucose monitoring strip or routine screening test, on the other hand, is typically classified as lower-level and has a shorter approval process. The distinction between the two is not insignificant; it is the difference between a few months of compliance work and a genuinely lengthy, technically challenging approval process.
What This Means for Your Business Plan
If you’re set on a specific product, such as an HIV or Hepatitis test kit, be aware that you’re entering the most closely regulated rung of the industry, and plan your budget, staff, and timeframe appropriately. If you’re flexible about where you begin, a lower-class product (regular screening tests, blood grouping kits, or similar) provides a really speedier, lower-cost path to your first income while you gain manufacturing expertise and compliance credibility before attempting a higher-class product later.
The Indian Market, Honestly Assessed
According to Mordor Intelligence, India’s in-vitro diagnostics market is expected to be worth over USD 1.94 billion in 2026 and USD 2.66 billion by 2031, representing a stable 6.49% annual growth rate. This is genuine, real growth linked to expanding healthcare access and diagnostic infrastructure, not hype — but it’s also worth noting that regulatory requirements have recently tightened rather than loosened: mandatory local clinical validation for many IVDs was reinstated in October 2024 after an earlier waiver was revoked, extending approval timelines for higher-risk and AI-enabled diagnostic products. Plan your timeframe based on today’s tougher environment rather from an older, speedier method you may have read about.
How These Kits Are Actually Made
Most quick diagnostic kits operate on the same underlying principle: a sample (blood, serum, or plasma) flows across a nitrocellulose membrane strip coated with specific antibodies or antigens, resulting in a visible line if the target chemical is present. Manufacturing normally follows the following sequence:
- Reagent and antibody/antigen preparation entails obtaining or creating the biological components that give the test its specificity and sensitivity.
- Membrane striping is the exact application of antibody/antigen lines to a nitrocellulose membrane using specialized stripping equipment.
- Conjugate pad and sample pad assembly involves preparing the pads that transport the sample over the membrane.
- Cassette assembly entails placing the completed membrane strip within the standard plastic cassette container seen in any quick test kit.
- Quality control testing consists of batch testing for sensitivity, specificity, and consistency prior to release, as this is the step that regulators pay the most attention to.
- Individual kits are sealed into foil pouches with desiccant to avoid moisture damage, followed by labelling and batch tagging for complete traceability, both in accordance with CDSCO labelling rules.
Raw Materials You'll Need
Nitrocellulose membranes, antibodies and antigens (the biological heart of the test and often the most technically demanding component to source or develop reliably), plastic cassette housings, conjugate materials (typically gold nanoparticles or latex particles that produce the visible test line), and packaging materials such as foil pouches and desiccant are among the primary inputs. Antibody/antigen source quality has a direct impact on the accuracy of your kit; regardless of the product class you’re targeting, this is not an area to cut corners on.
Licenses You'll Need
Requirement | What It Involves |
Medical Device Manufacturing Licence (CDSCO) | Required under the Medical Devices Rules, 2017; issued by the Central Drugs Standard Control Organisation, with the exact form and process depending on your device’s class |
ISO 13485 Certification | Quality management system standard expected for medical device manufacturers |
Performance Evaluation | Testing against India-specific epidemiological data, especially critical for infectious disease kits |
NACO Clearance (for HIV kits specifically) | An additional layer required for HIV diagnostic kits, on top of standard CDSCO approval |
Udyam & GST Registration | Standard business registrations enabling scheme eligibility and tax compliance |
Investment: Why There's No Single Answer
Investment in this firm varies more than in virtually any other manufacturing sector, because your product class directly influences your cost. A basic rapid test kit line (moderate-risk category, simpler compliance path) requires significantly less capital and compliance spend than a Class D infectious disease screening kit line, which necessitates more sophisticated quality systems, performance validation studies, and a longer pre-revenue compliance timeline. Rather than quoting a single figure that could mislead you in either direction, the honest advice is to first confirm your product’s classification, and then build your machinery and compliance budget around that specific classification’s actual requirements, using current supplier and regulatory consultant quotes.
Financing Options
Route | Best Fit |
PMEGP | Lower-class, smaller-scale kit manufacturing where compliance costs fit within the scheme’s project cost cap |
CGTMSE | Collateral-free lending through a bank guarantee, relevant for most MSME-scale operations in this space |
Standard MSME term loan | Mid-to-higher class products given the larger investment and compliance runway typically required |
PLI Scheme for Medical Devices | Larger-scale manufacturing with genuine domestic value addition, particularly relevant for higher-class diagnostic products |
Whatever route you choose, your project report needs to reflect your actual product class and realistic approval timeline in its cash flow and DSCR projections — most banks require a minimum DSCR of around 1.25, and a projection that assumes revenue starts immediately after machinery installation, without accounting for your specific classification’s approval runway, is one of the most common reasons these applications face delay.
Where Buyers Actually Come From
Your realistic customer base includes hospitals and diagnostic laboratories, clinics and point-of-care testing centers, public health and screening program procurement (a genuinely significant channel given India’s ongoing public health infrastructure investment), pharmacy and home-testing retail channels for consumer-facing products, and OEM/private-label arrangements supplying established diagnostic brands — often a more realistic entry point for a new manufacturer.
Mistakes That Cost the Most Time and Money
- Selecting a product before confirming its correct medical device classification.
- Ignoring regulatory requirements during product development and planning.
- Underestimating approval timelines and compliance-related expenses.
- Using low-quality raw materials to reduce manufacturing costs.
- Overlooking product accuracy and quality validation requirements.
- Failing to include clinical validation costs in financial planning.
- Preparing unrealistic cash flow and working capital estimates.
- Starting production before completing required regulatory approvals.
Frequently Asked Questions
No. Blood test kits are divided into medical device risk categories depending on their intended usage and potential influence on patient care. Regulatory restrictions differ depending on the product classification.
Manufacturers typically require suitable medical device manufacturing licenses, regulatory permits, quality management certificates, and other registrations based on the type of diagnostic kit being produced.
Yes. Higher-risk diagnostic items typically require more rigorous regulatory evaluations, validation criteria, quality controls, and paperwork than lower-risk diagnostic equipment.
Yes, entrepreneurs can qualify for MSME loans and other company finance. Banks typically evaluate project viability, investment, compliance requirements, and financial projections prior to approval.
Investment is determined by the type of diagnostic kit, manufacturing capacity, laboratory setup, machinery, regulatory requirements, and production technology. Actual expenses vary according to project size.
Machinery varies according to product type, however it may include reagent preparation systems, filling machines, sealing equipment, packaging machines, testing instruments, and quality control laboratory equipment.
Hospitals, diagnostic laboratories, blood banks, healthcare institutions, government organizations, and medical equipment distributors are the primary customers in both domestic and foreign markets.
Major hurdles include regulatory compliance, product validation, testing accuracy, quality control, documentation, and competing with established diagnostic manufacturers.
Yes. ISO 13485 and other quality management certifications enable medical device manufacturers to establish compliance, boost trust, and support regulatory approval.